Product Images Oxybutynin Chloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Oxybutynin Chloride NDC 68151-3646 by Carilion Materials Management, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label Image - lbl681513646

Label Image - lbl681513646

This is a description of Oxybutynin Chloride Extended-Release tablets manufactured by IMPAX. Each tablet contains 5mg of the medication and is intended for prescription use only. The lot number is 10007041 and the expiration date is 09/14. The code "W0311143m6" is also present but its meaning is unknown.*

Chemical Structure - oxybutynin chloride extended release tablets 1

Chemical Structure - oxybutynin chloride extended release tablets 1

Figure 1 - oxybutynin chloride extended release tablets 2

Figure 1 - oxybutynin chloride extended release tablets 2

Figure 2 - oxybutynin chloride extended release tablets 3

Figure 2 - oxybutynin chloride extended release tablets 3

Figure - oxybutynin chloride extended release tablets 4

Figure - oxybutynin chloride extended release tablets 4

The text is a graph showing the mean change in episodes per week from baseline for Oxybutynin Chloride Extended-Release Tablets compared to a placebo. There is no further information available from the given text.*

Figure - oxybutynin chloride extended release tablets 5

Figure - oxybutynin chloride extended release tablets 5

Figure - oxybutynin chloride extended release tablets 6

Figure - oxybutynin chloride extended release tablets 6

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.